NEW YORK (GenomeWeb) – Biogen Idec and Columbia University Medical Center today announced they have signed a $30 million agreement to establish a research facility to study the genetics of disease and find new drug targets.

The partners will build a sequencing and analysis facility and create a postdoctoral program at Columbia to support collaborative genetics studies. The agreement, they said, brings together genomics research conducted at Columbia with Biogen's expertise in discovering new medicines.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.